BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15567415)

  • 1. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.
    Mac Sweeney A; Lange R; Fernandes RP; Schulz H; Dale GE; Douangamath A; Proteau PJ; Oefner C
    J Mol Biol; 2005 Jan; 345(1):115-27. PubMed ID: 15567415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase from the hyperthermophile Thermotoga maritima for insights into the coordination of conformational changes and an inhibitor binding.
    Takenoya M; Ohtaki A; Noguchi K; Endo K; Sasaki Y; Ohsawa K; Yajima S; Yohda M
    J Struct Biol; 2010 Jun; 170(3):532-9. PubMed ID: 20353826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin.
    Yajima S; Hara K; Iino D; Sasaki Y; Kuzuyama T; Ohsawa K; Seto H
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jun; 63(Pt 6):466-70. PubMed ID: 17554164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Mercklé L; de Andrés-Gómez A; Dick B; Cox RJ; Godfrey CR
    Chembiochem; 2005 Oct; 6(10):1866-74. PubMed ID: 16116659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1.9 A resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target.
    Henriksson LM; Björkelid C; Mowbray SL; Unge T
    Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):807-13. PubMed ID: 16790937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase: an overview.
    Proteau PJ
    Bioorg Chem; 2004 Dec; 32(6):483-93. PubMed ID: 15530989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase.
    Silber K; Heidler P; Kurz T; Klebe G
    J Med Chem; 2005 May; 48(10):3547-63. PubMed ID: 15887963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
    J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase provide new insights into catalysis.
    Henriksson LM; Unge T; Carlsson J; Aqvist J; Mowbray SL; Jones TA
    J Biol Chem; 2007 Jul; 282(27):19905-16. PubMed ID: 17491006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5-phosphate reductoisomerase complexes.
    Yajima S; Hara K; Sanders JM; Yin F; Ohsawa K; Wiesner J; Jomaa H; Oldfield E
    J Am Chem Soc; 2004 Sep; 126(35):10824-5. PubMed ID: 15339150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies addressing the importance of charge in the binding of fosmidomycin-like molecules to deoxyxylulosephosphate reductoisomerase.
    Perruchon J; Ortmann R; Altenkämper M; Silber K; Wiesner J; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1232-41. PubMed ID: 18470849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies on Mycobacterium tuberculosis DXR in complex with the antibiotic FR-900098.
    Björkelid C; Bergfors T; Unge T; Mowbray SL; Jones TA
    Acta Crystallogr D Biol Crystallogr; 2012 Feb; 68(Pt 2):134-43. PubMed ID: 22281742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies of DOXP reductoisomerase and its inhibitor complex.
    Englert NE; Richter C; Wiesner J; Hintz M; Jomaa H; Schwalbe H
    Chembiochem; 2011 Feb; 12(3):468-76. PubMed ID: 21290548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the flexible loop of 1-deoxy-D-xylulose 5-phosphate reductoisomerase broadens substrate utilization.
    Fernandes RP; Phaosiri C; Proteau PJ
    Arch Biochem Biophys; 2005 Dec; 444(2):159-64. PubMed ID: 16289362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
    Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
    J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr).
    Behrendt CT; Kunfermann A; Illarionova V; Matheeussen A; Pein MK; Gräwert T; Kaiser J; Bacher A; Eisenreich W; Illarionov B; Fischer M; Maes L; Groll M; Kurz T
    J Med Chem; 2011 Oct; 54(19):6796-802. PubMed ID: 21866890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Woo YH; Fernandes RP; Proteau PJ
    Bioorg Med Chem; 2006 Apr; 14(7):2375-85. PubMed ID: 16310360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase complexed with cofactors: implications of a flexible loop movement upon substrate binding.
    Yajima S; Nonaka T; Kuzuyama T; Seto H; Ohsawa K
    J Biochem; 2002 Mar; 131(3):313-7. PubMed ID: 11872159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of Brucella abortus deoxyxylulose-5-phosphate reductoisomerase-like (DRL) enzyme involved in isoprenoid biosynthesis.
    Pérez-Gil J; Calisto BM; Behrendt C; Kurz T; Fita I; Rodríguez-Concepción M
    J Biol Chem; 2012 May; 287(19):15803-9. PubMed ID: 22442144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards new antimalarial drugs: synthesis of non-hydrolyzable phosphate mimics as feed for a predictive QSAR study on 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitors.
    Giessmann D; Heidler P; Haemers T; Van Calenbergh S; Reichenberg A; Jomaa H; Weidemeyer C; Sanderbrand S; Wiesner J; Link A
    Chem Biodivers; 2008 Apr; 5(4):643-56. PubMed ID: 18421757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.